|
7911 |
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN)
Enthalten in Journal of neurology Bd. 270, 8.8.2023, Nr. 11, date:11.2023: 5600-5612
|
|
|
|
7912 |
The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over study
Enthalten in Critical care Bd. 13, 13.5.2009, Nr. 3, date:6.2009: 1-6
|
|
|
|
7913 |
The effect of extracorporeal shock wave therapy in acute traumatic spinal cord injury on motor and sensory function within 6 months post-injury: a study protocol for a two-arm three-stage adaptive, prospective, multi-center, randomized, blinded, placebo-controlled clinical trial
Enthalten in Trials Bd. 23, 1.4.2022, Nr. 1, date:12.2022: 1-13
|
|
|
|
7914 |
The effect of follow-up after a negative double-blinded placebo-controlled cow’s milk challenge on successful reintroduction
Enthalten in Zeitschrift für Kinderheilkunde Bd. 178, 24.5.2019, Nr. 7, date:7.2019: 1113-1117
|
|
|
|
7915 |
The effect of gallium arsenide aluminum laser therapy in the management of cervical myofascial pain syndrome: a double blind, placebo-controlled study
Enthalten in Clinical rheumatology Bd. 26, 5.10.2006, Nr. 6, date:6.2007: 930-934
|
|
|
|
7916 |
The Effect of Guselkumab on General Health State in Biologic-Naïve Patients with Active Psoriatic Arthritis Through Week 52 of the Phase 3, Randomized, Placebo-Controlled DISCOVER-2 Trial
Enthalten in Advances in therapy Bd. 39, 10.8.2022, Nr. 10, date:10.2022: 4632-4644
|
|
|
|
7917 |
The effect of guselkumab on inhibiting radiographic progression in patients with active psoriatic arthritis: study protocol for APEX, a Phase 3b, multicenter, randomized, double-blind, placebo-controlled trial
Enthalten in Trials Bd. 24, 10.1.2023, Nr. 1, date:12.2023: 1-12
|
|
|
|
7918 |
The Effect of Guselkumab on Work Productivity in Biologic-Naïve Patients with Active Psoriatic Arthritis Through Week 52 of the Phase 3, Randomized, Placebo-Controlled DISCOVER-2 Trial
Enthalten in Advances in therapy Bd. 39, 10.8.2022, Nr. 10, date:10.2022: 4613-4631
|
|
|
|
7919 |
The effect of homocysteine-lowering with B-vitamins on osteoporotic fractures in patients with cerebrovascular disease: substudy of VITATOPS, a randomised placebo-controlled trial
Enthalten in BMC geriatrics Bd. 13, 3.9.2013, Nr. 1, date:12.2013: 1-9
|
|
|
|
7920 |
The effect of hormonal contraceptives combined with vitamin D3 supplements on sexual dysfunction in women with polycystic ovary syndrome: a randomized double-blind placebo-controlled trial
Enthalten in Archives of gynecology and obstetrics Bd. 312, 6.9.2025, Nr. 5, date:11.2025: 1737-1746
|
|
Administration
